| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68462-882-60 | 68462-882 | HUMAN PRESCRIPTION DRUG | abiraterone acetate | abiraterone acetate | TABLET | ORAL | 20220519 | N/A | ANDA | ANDA209227 | Glenmark Pharmaceuticals Inc., USA | ABIRATERONE ACETATE | 500 mg/1 | 60 TABLET in 1 BOTTLE (68462-882-60) |
| 72603-111-01 | 72603-111 | HUMAN PRESCRIPTION DRUG | abiraterone acetate | abiraterone acetate | TABLET | ORAL | 20220519 | N/A | ANDA | ANDA209227 | NORTHSTAR RX LLC | ABIRATERONE ACETATE | 500 mg/1 | 60 TABLET in 1 BOTTLE (72603-111-01) |
| 68462-135-08 | 68462-135 | HUMAN PRESCRIPTION DRUG | abiraterone acetate | abiraterone acetate | TABLET | ORAL | 20191016 | N/A | ANDA | ANDA209227 | Glenmark Pharmaceuticals Inc., USA | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE (68462-135-08) |
| 72603-110-01 | 72603-110 | HUMAN PRESCRIPTION DRUG | abiraterone acetate | abiraterone acetate | TABLET | ORAL | 20220307 | N/A | ANDA | ANDA209227 | NORTHSTAR RX LLC | ABIRATERONE ACETATE | 250 mg/1 | 120 TABLET in 1 BOTTLE (72603-110-01) |